Regulatory B Cell Repertoire Defects Predispose Lung Cancer Patients to Immune-Related Toxicity Following Checkpoint Blockade

Scientists showed that in non-small cell lung cancer patients, a deficient regulatory B cell checkpoint failed to limit self-reactive T cell enhanced activity and auto-antibody formation enabled by PD-1/PD-L1 blockade, leading to severe auto-inflammatory sequelae.